Rocket Pharmaceuticals Inc. (RCKT)

Sector:Health Care
Super Investor Stats:
Ownership count:2
Ownership rank:360
% of all portfolios:0.034%
Hold Price * :$29.69
History Portfolio Manager Activity Share change % change to portfolio
Q1  2024
Torray Funds Add 0.13% 77 0.00
Q4  2023
Torray Funds Add 1.13% 679 0.00
Lee Ainslie - Maverick Capital Reduce 28.35% 1,595,902 0.99
Q3  2023
Lee Ainslie - Maverick Capital Add 28.54% 1,250,000 0.60
Torray Funds Add 10.28% 5,608 0.02
Q2  2023
Torray Funds Add 0.62% 337 0.00
Lee Ainslie - Maverick Capital Reduce 0.63% 27,653 0.01
Q1  2023
Lee Ainslie - Maverick Capital Add 29.80% 1,011,805 0.45
Torray Funds Reduce 0.17% 92 0.00
Q4  2022
Lee Ainslie - Maverick Capital Add 34.10% 863,452 0.41
Torray Funds Reduce 4.61% 2,627 0.01
Q3  2022
Torray Funds Reduce 5.83% 3,524 0.01
Q2  2022
Torray Funds Add 38.53% 16,820 0.04
Lee Ainslie - Maverick Capital Add 18.71% 399,200 0.14
Q1  2022
Torray Funds Add 19.77% 7,206 0.02
Lee Ainslie - Maverick Capital Add 12.57% 238,200 0.07
Q4  2021
Lee Ainslie - Maverick Capital Add 14.15% 234,850 0.06
Torray Funds Reduce 3.53% 1,333 0.00
Q3  2021
Lee Ainslie - Maverick Capital Add 854.71% 1,486,229 0.49
Torray Funds Add 1.13% 422 0.00
Q2  2021
Torray Funds Add 28.56% 8,299 0.05
Lee Ainslie - Maverick Capital Buy 173,887 0.07
Q1  2021
Torray Funds Reduce 15.68% 5,403 0.04
Q4  2020
Torray Funds Reduce 29.37% 14,331 0.13
Q3  2020
Torray Funds Add 0.45% 218 0.00
Q2  2020
Torray Funds Reduce 13.96% 7,881 0.03
Q1  2020
Torray Funds Add 87.83% 26,400 0.08
Q4  2019
Torray Funds Buy 30,058 0.12

* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.